Search

Your search keyword '"Sherwood, Matthew W."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Sherwood, Matthew W." Remove constraint Author: "Sherwood, Matthew W." Database MEDLINE Remove constraint Database: MEDLINE
78 results on '"Sherwood, Matthew W."'

Search Results

1. Guideline-directed medical therapy implementation during hospitalization for cardiogenic shock.

2. Impact of anemia on outcomes and resource utilization in patients with myocardial infarction: A national database analysis.

3. Best practices for vascular arterial access and closure: a contemporary guide for the cardiac catheterization laboratory.

4. Do Clinical Outcomes and Quality of Life Differ by the Number of Antianginals for Stable Ischemic Heart Disease? Insights from the BARI 2D Trial.

6. A Randomized Comparison of Radial Artery Intimal Hyperplasia Following Distal Versus Proximal Transradial Access for Coronary Angiography: PRESERVE RADIAL.

7. What Do We Really Know About Transcatheter Mitral Valve-in-Valve Procedures?

8. Health Benefits of Transcatheter Tricuspid Valve Repair: Is it Enough to Simply Feel Better?

9. Medical Management and Device-Based Therapies in Chronic Heart Failure.

10. The Search for Optimal Antithrombotic Therapy With LAAO: Are We There Yet?

11. Sex-Related Differences in Patient Characteristics, Hemodynamics, and Outcomes of Cardiogenic Shock: INOVA-SHOCK Registry.

12. A Randomized Comparison of Radial Artery Intimal Hyperplasia Following Distal vs. Proximal Transradial Access for Coronary Angiography: PRESERVE RADIAL Trial.

14. Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.

15. Executive Summary: Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline.

16. A Standardized and Regionalized Network of Care for Cardiogenic Shock.

17. The Busy Life of an Early Career Cardiologist: The Juggle Is Real!

19. Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes.

20. The heart of the matter: modulating therapeutic effects of adrenomedullin in cardiogenic shock.

21. For TAVR, Home Is Where the Heart Is.

22. Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation.

23. Getting (Left Atrial Appendage) Closure With Kidney Disease.

24. Myocarditis Temporally Associated With COVID-19 Vaccination.

25. Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.

26. Does study subject diversity influence cardiology research site performance?: Insights from 2 U.S. National Coronary Stent Registries.

27. Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.

28. Ventricular septal rupture and cardiogenic shock complicating STEMI during COVID-19 pandemic: An old foe re-emerges.

29. Is Transcatheter Aortic Valve Replacement Worth the Wait?

30. The clinical spectrum of myocardial injury associated with COVID-19 infection.

31. Transcatheter Aortic Valve Replacement in Low-Population Density Areas: Assessing Healthcare Access for Older Adults With Severe Aortic Stenosis.

32. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.

33. Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice: An Analysis of the ORBIT II Registry.

34. Incidence, Temporal Trends, and Associated Outcomes of Vascular and Bleeding Complications in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry.

35. Percutaneous coronary intervention outcomes in patients with stable coronary disease and left ventricular systolic dysfunction.

36. Incidence and Outcomes of Surgical Bailout During TAVR: Insights From the STS/ACC TVT Registry.

37. Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry.

38. Standardized Team-Based Care for Cardiogenic Shock.

39. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary Intervention.

40. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.

41. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.

42. Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry.

43. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.

44. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial.

45. Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial.

46. Challenges in Aortic Valve Stenosis: Low-Flow States Diagnosis, Management, and a Review of the Current Literature.

47. Impact of Regional Systems of Care on Disparities in Care Among Female and Black Patients Presenting With ST-Segment-Elevation Myocardial Infarction.

48. Peripheral Artery Disease and Transcatheter Aortic Valve Replacement Outcomes: A Report From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Therapy Registry.

49. Outcomes of PCI in Relation to Procedural Characteristics and Operator Volumes in the United States.

50. Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR.

Catalog

Books, media, physical & digital resources